Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BYEuropean Journal of Medical Research

Associations of vitamins D3 and K2 supplementation on fetal growth restriction-related skeletal development abnormalities and their potential mechanisms

  1. 1Department of Obstetrics, Peking University First Hospital, Taiyuan Hospital (Taiyuan Central Hospital)

Abstract

Background Fetal growth restriction (FGR) is a major cause of perinatal morbidity and mortality and is often associated with placental dysfunction and impaired angiogenesis. Although vitamin D3 (VD3) and vitamin K2 (VK2) are involved in vascular regulation, their potential associations with FGR and related molecular mechanisms remain incompletely understood. Methods A retrospective cohort study was conducted involving 200 pregnancies diagnosed with FGR, of whom 98 received adjunct VD3+VK2 supplementation and 102 received standard management alone. Birthweight Z-scores, severe FGR, perinatal outcomes, skeletal development indicators, placental pathology, and maternal metabolic markers were compared. Transcriptomic analysis (GSE24129) was used to identify VD3+VK2-related FGR genes. Differentially expressed genes (DEGs) were intersected with VD3/VK2 predicted targets, followed by protein–protein interaction (PPI) network construction, hub gene analysis, and multi-algorithm machine learning (SVM-RFE, LASSO, random forest). Results VD3+VK2 supplementation was significantly associated with higher birthweight Z-scores (β=0.19, P=0.009), a lower risk of severe FGR (adjusted OR=0.57, P=0.041), and reduced composite adverse perinatal outcomes (adjusted OR=0.52, P=0.037). Neonatal skeletal indices, placental weight, and placental pathology scores also improved. Bioinformatics identified 52 VD3+VK2-related FGR genes and 10 hub genes, among which THBS1 emerged as the only consistent key feature across three machine-learning algorithms. In vitro, combined VD3+VK2 treatment was associated with attenuation of H2O2-induced endothelial injury, reduced THBS1, and partial restoration of cell viability, migration, and tube formation; forced THBS1 overexpression reversed these beneficial effects. Conclusions Adjunct VD3+VK2 supplementation is associated with improved fetal growth and perinatal outcomes in pregnancies complicated by FGR. The present findings also suggest a potential association between THBS1-related endothelial responses and the observed effects of combined VD3+VK2 treatment. Further prospective and mechanistic studies are warranted to validate these observations and clarify the potential clinical relevance of VD3+VK2 supplementation in FGR management.

Related

  1. Melatonin Supplementation During Middle Gestation Alleviates Intrauterine Growth Restriction in Piglets and Is Associated with Alterations in Placental DNA Methylation
    Likai Wang, Huigang Han, Zhenhua Xue +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMC
  2. Associations of Coexisting Metabolic Dysfunction‐Associated Steatotic Liver Disease and Sarcopenia‐Related Abnormalities With Adverse Clinical Outcomes Across Obesity States
    Hong Fan, Xianhua Mao, Taotao Yan +5
    MedCommPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCEurope PMCPMC
  3. Gastric motility abnormalities in pediatric gastroesophageal reflux disease: A comprehensive review of mechanisms and therapeutic implications
    Niranga Manjuri Devanarayana, Shaman Rajindrajith
    World Journal of Clinical PediatricsPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  4. Long-term myocardial deformation abnormalities and biomarker associations in pediatric myopericarditis: a speckle-tracking echocardiographic study
    Sule Arici, Selen Karagozlu, Elif Erolu Kibris +1
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref
  5. Gender-specific associations between metabolic syndrome components and electrocardiographic abnormalities: evidence from Birjand University of medical sciences employee health study (BUMS EHCS)
    Mostafa Parizadeh, Mahnaz Bahrami, Samira Karbasi +4
    Scientific ReportsPeer-reviewedCC BYFull text1 citedEndocrinology & metabolismDOAJ
BibTeX
@article{wang2026associations,
  title = {{Associations of vitamins D3 and K2 supplementation on fetal growth restriction-related skeletal development abnormalities and their potential mechanisms}},
  author = {Lijuan Wang and Junzhi Yang and Rihong Ding},
  journal = {European Journal of Medical Research},
  year = {2026},
  month = jul,
  doi = {10.1186/s40001-026-04760-8},
  url = {https://doi.org/10.1186/s40001-026-04760-8},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Associations of vitamins D3 and K2 supplementation on fetal growth restriction-related skeletal development abnormalities and their potential mechanisms
AU  - Lijuan Wang
AU  - Junzhi Yang
AU  - Rihong Ding
PY  - 2026
DA  - 2026/07/01
JO  - European Journal of Medical Research
DO  - 10.1186/s40001-026-04760-8
UR  - https://doi.org/10.1186/s40001-026-04760-8
AB  - Background Fetal growth restriction (FGR) is a major cause of perinatal morbidity and mortality and is often associated with placental dysfunction and impaired angiogenesis. Although vitamin D3 (VD3) and vitamin K2 (VK2) are involved in vascular regulation, their potential associations with FGR and related molecular mechanisms remain incompletely understood. Methods A retrospective cohort study was conducted involving 200 pregnancies diagnosed with FGR, of whom 98 received adjunct VD3+VK2 supplementation and 102 received standard management alone. Birthweight Z-scores, severe FGR, perinatal outcomes, skeletal development indicators, placental pathology, and maternal metabolic markers were compared. Transcriptomic analysis (GSE24129) was used to identify VD3+VK2-related FGR genes. Differentially expressed genes (DEGs) were intersected with VD3/VK2 predicted targets, followed by protein–protein interaction (PPI) network construction, hub gene analysis, and multi-algorithm machine learning (SVM-RFE, LASSO, random forest). Results VD3+VK2 supplementation was significantly associated with higher birthweight Z-scores (β=0.19, P=0.009), a lower risk of severe FGR (adjusted OR=0.57, P=0.041), and reduced composite adverse perinatal outcomes (adjusted OR=0.52, P=0.037). Neonatal skeletal indices, placental weight, and placental pathology scores also improved. Bioinformatics identified 52 VD3+VK2-related FGR genes and 10 hub genes, among which THBS1 emerged as the only consistent key feature across three machine-learning algorithms. In vitro, combined VD3+VK2 treatment was associated with attenuation of H2O2-induced endothelial injury, reduced THBS1, and partial restoration of cell viability, migration, and tube formation; forced THBS1 overexpression reversed these beneficial effects. Conclusions Adjunct VD3+VK2 supplementation is associated with improved fetal growth and perinatal outcomes in pregnancies complicated by FGR. The present findings also suggest a potential association between THBS1-related endothelial responses and the observed effects of combined VD3+VK2 treatment. Further prospective and mechanistic studies are warranted to validate these observations and clarify the potential clinical relevance of VD3+VK2 supplementation in FGR management.
SN  - 2047-783X
ER  -